# EDGAR Filing Document

**Accession Number:** 0000811240
**File Stem:** 0001193125-23-001554
**Filing Date:** 2023-1
**Character Count:** 3138
**Document Hash:** adcaa0eaa736ff8be47787ef6a0970fa
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-001554.hdr.sgml**: 20230207

**ACCESSION NUMBER**: 0001193125-23-001554

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230104

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** BIOLASE, INC
- **CENTRAL INDEX KEY:** 0000811240
- **STANDARD INDUSTRIAL CLASSIFICATION:** DENTAL EQUIPMENT & SUPPLIES [3843]
- **IRS NUMBER:** 870442441
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 27042 TOWNE CENTRE DRIVE
- **STREET 2:** SUITE 270
- **CITY:** FOOTHILL RANCH
- **STATE:** CA
- **ZIP:** 92610
- **BUSINESS PHONE:** 949-361-1200

**MAIL ADDRESS:**
- **STREET 1:** 27042 TOWNE CENTRE DRIVE
- **STREET 2:** SUITE 270
- **CITY:** FOOTHILL RANCH
- **STATE:** CA
- **ZIP:** 92610

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BIOLASE TECHNOLOGY INC
- **DATE OF NAME CHANGE:** 19941117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LASER MEDICAL TECHNOLOGY INC
- **DATE OF NAME CHANGE:** 19941117

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** LASER ENDO TECHNIC CORP
- **DATE OF NAME CHANGE:** 19920708

January 4, 2023

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

---

| | |
|:---|:---|
| **Re:** | **Biolase, Inc.**  |

---

**Registration Statement on Form S-1, as amended** 

**File No. 333-268528** 

**Request for Acceleration of Effective Date** 

Ladies and Gentlemen:

Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the "**Securities Act**"), Lake Street Capital Markets, LLC, as the representative of the several underwriters, hereby joins in the request of Biolase, Inc. for acceleration of the effective date of the above-referenced registration statement on Form S-1, as amended (the "**Registration Statement**"), so that it becomes effective as of 5:00 p.m. Eastern Time on Thursday, January 5, 2023, or as soon thereafter as possible.

Pursuant to Rule 460 of the General Rules and Regulations of the Securities Act, we wish to advise you that we have distributed approximately 500 copies of the preliminary prospectus to prospective underwriters, institutional investors, dealers and others.

The undersigned has and will comply, and it has been informed or will be informed by any participating dealers that they have complied or will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

*[Signature Page to Follow]* 

------

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| **LAKE STREET CAPITAL MARKETS, LLC** | **LAKE STREET CAPITAL MARKETS, LLC** |
| *As Representative of the Several Underwriters* | *As Representative of the Several Underwriters* |
| *Named in the Underwriting Agreement* | *Named in the Underwriting Agreement* |
| By: | /s/ Michael Townley |
|  | Name: Michael Townley |
|  | Title: Head of Investment Banking |

---

*[Signature Page to Underwriters' Acceleration Request]*